Abstract
In 1967 Prensky et al. reported the accumulation of ceramide in the postmortem tissues of a patient with Faber’s disease (1), and in 1971 Samuelsson and Zetterstrom reported such an accumulation in a second case (2). In 1972 Sugita, Dulaney and Moser demonstrated the deficient activity of an acid ceramidase in the tissues of the case reported by Prensky et al., (3). Since this same enzymatic defect has now been demonstrated in three additional unrelated patients, it appears likely that the deficient activity of acid ceramidase represents the basic defect in this disease, and makes it appropriate to appraise our current knowledge about this striking rare disorder.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Prensky, A. L., Ferreira, G., Carr, S. and Moser, H. W. Ceramide and ganglioside accumulation in Faber’s lipogranulomatosis. Proc. Soc. Exp. Biol. Med. 126: 725–728, 1967
Samuelsson, K. and Zetterstrom, R. Ceramides in a patient with lipogranulomatosis (Faber’s disease) with chronic course. Scand. J. Clin. Lab, Invest. 27: 393–405, 1971
Sugita, M., Dulaney, J. T. and Moser, H. W. Ceramidase deficiency in Faber’s disease (lipogranulomatosis). Science 178: 1100–1102, 1972
Faber, S., Cohen, J. and Uzman, L. L. Lipogranulomatosis. A new lipoglyco-protein “storage” disease. J. Mt. Sinai Hosp. 24: 816–837, 1957
Crocker, A. C., Cohen, J. and Faber, S. The “Lipogranulomatosis” syndrome; Review, with report of patient showing milder involvement. In: Inborn Disorders of Sphingolipid Metabolism. Edited by S. M. Aronson and B. W. Volk. Pergamon Press, Ltd., Oxford, 1967, pp. 485–503
Moser, H. W., Prensky, A. L., Wolfe, H. J. and Rosman, N. P. with the technical assistance of S. Carr and G. Ferreira. Faber’s lipogranulomatosis. Report of a case and demonstration of an excess of free ceramide and ganglioside. Amer. J. Med. 47: 869–890, 1969
Cogan, D. G., Kuwabara, T., Moser, H. and Hazard, G. W. Retinopathy in a case of Faber’s lipogranulomatosis. Arch. Ophthal. 75: 752–757, 1966
Abul-Haj, S. K., Martz, D. G., Douglas, W. F. and Geppert, L. J. Faber’s disease. Report of a case with observations on its histogenesis and notes on the nature of the stored material. J. Pediat. 61: 221–232, 1962
Dustin, P., Tondeur, M., Jonniaux, G., Vamos-Hurwitz, E. and Pelc, S. La maladie de Faber. Etude anatomo-clinique et ultrastructurale. Bull. Acad. Med. Belg. 128: 733–762, 1973
Barriere, H. and Gillot, F. La lipogranulomatose de Faber. Nouv. Presse med. 2: 767–770, 1973
Van Hoof, F. and Hers, H. G. Farber’s disease. In: Lysosomes and Storage Diseases. Edited by H. G. Hers and F. Van Hoof. Academic Press, Inc. N. Y., 1973, pp. 559–563
Bierman, S. M., Edgington, T., Newcomer, V. D. and Pearson, C. M. Faber’s disease: A disorder of mucopolysaccharide metabolism with articular, respiratory, and neurologic manifestations. Arthritis & Rheumat. 9: 620–630, 1966
Rampini, S. and Clausen, J. Farbersche Krankheit (disseminierte Lipogranulomatose) Klinisches Bild und Zusammenfassung der chemischen Befunde. Helvetica Paediatrica Acta 22: 500–515, 1967
Battin, P. J., Vital, C. L. and Azanza, X. Une neurolipidose rare avec lesions nodulaires sous-cutanees et articulaires: La lipogranulomatose disseminee de Farber. Annales de Dermatologie et de Syphiligraphie, Paris, 97: 241–248, 1970
Schonenberg, H., and Lindenfeiser, R. Faber-Syndrom (Disseminierte lipogranulomatose). Mschr. Kinderheilk 122: 153–159, 1974
Zetterstrom, R. Disseminated lipogranulomatosis (Farber’s disease). Acta Paediatr. 47: 501–510, 1958
Clausen, J. and Rampini, S. Chemical studies of Farber’s disease. Acta Neurol. Scandinav. 46: 313–322, 1970
Iwamori, M. and Moser, H. W. Above-normal urinary excretion of urinary ceramides in Faber’s disease, and characterization of their components by high-performance liquid chromatography. Clin. Chem. 21: 725–729, 1975
Sugita, M., Connolly, P., Dulaney, J. T. and Moser, H. W. Fatty acid composition of free ceramides of kidney and cerebellum from a patient with Faber’s disease. Lipids 8: 401–406, 1973
Philippart, M., Nakatani, S., Zeilstra, K., Tondeur, M., Vamos-Hurwitz, E. and Pelc, S. Faber’s disease: Ceramide accumulation in cultured skin fibroblasts. Trans. Amer. Soc. Neurochem. 6: 152, 1975
Dulaney, J. T., Milunsky, A., Moser, H. W. Diagnosis of Farber’s disease by use of cultured fibroblasts. Submitted for publication, 1975
Gatt, S., Enzymatic hydrolysis of sphingolipids. I. Hydrolysis and synthesis of ceramides by an enzyme from rat brain. J. Biol. Chem. 241: 3724–3730, 1966
Yavin, E. and Gatt, S. Enzymatic hydrolysis of sphingolipids. VIII. Further purification and properties of rat brain ceramidase. Biochemistry 8: 1692–1698, 1969
Sribney, M. Enzymatic synthesis of ceramide. Biochim. Biophys. Acta. 125: 542–547, 1966
Sugita, M., Williams, M., Dulaney, J. T. and Moser, H. W. Ceramidase and ceramide synthesis in human kidney and cerebellum. Description of a new alkaline ceramidase. Biochim. Biophys. Acta. 398: 125–131, 1975
Nilsson, A. The presence of sphingomyelin-and ceramidecleaving enzymes in the small intestinal tract. Biochim. Biophys. Acta 176: 339–347, 1969
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1976 Plenum Press, New York
About this chapter
Cite this chapter
Dulaney, J., Moser, H.W., Sidbury, J., Milunsky, A. (1976). The Biochemical Defect in Farber’s Disease. In: Volk, B.W., Schneck, L. (eds) Current Trends in Sphingolipidoses and Allied Disorders. Advances in Experimental Medicine and Biology, vol 68. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-7735-1_27
Download citation
DOI: https://doi.org/10.1007/978-1-4684-7735-1_27
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-7737-5
Online ISBN: 978-1-4684-7735-1
eBook Packages: Springer Book Archive